SU1158048A3 - Способ получени монаколина @ ,обладающего антигиперхолестеримическим действием - Google Patents

Способ получени монаколина @ ,обладающего антигиперхолестеримическим действием Download PDF

Info

Publication number
SU1158048A3
SU1158048A3 SU802887300A SU2887300A SU1158048A3 SU 1158048 A3 SU1158048 A3 SU 1158048A3 SU 802887300 A SU802887300 A SU 802887300A SU 2887300 A SU2887300 A SU 2887300A SU 1158048 A3 SU1158048 A3 SU 1158048A3
Authority
SU
USSR - Soviet Union
Prior art keywords
monacolin
obtaining
effect
possessing
antihypercholesterol
Prior art date
Application number
SU802887300A
Other languages
English (en)
Russian (ru)
Inventor
Эндо Акира
Original Assignee
Санкио Компани Лимитед (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед (Фирма) filed Critical Санкио Компани Лимитед (Фирма)
Application granted granted Critical
Publication of SU1158048A3 publication Critical patent/SU1158048A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SU802887300A 1979-02-20 1980-02-20 Способ получени монаколина @ ,обладающего антигиперхолестеримическим действием SU1158048A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンkおよびその製造法

Publications (1)

Publication Number Publication Date
SU1158048A3 true SU1158048A3 (ru) 1985-05-23

Family

ID=11955290

Family Applications (2)

Application Number Title Priority Date Filing Date
SU802887300A SU1158048A3 (ru) 1979-02-20 1980-02-20 Способ получени монаколина @ ,обладающего антигиперхолестеримическим действием
SU802977031A SU969702A1 (ru) 1979-02-20 1980-09-12 Монаколин К, обладающий гипохолестеримическим действием

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU802977031A SU969702A1 (ru) 1979-02-20 1980-09-12 Монаколин К, обладающий гипохолестеримическим действием

Country Status (27)

Country Link
JP (1) JPS5925599B2 (da)
KR (1) KR830002801B1 (da)
AT (1) AT373915B (da)
AU (1) AU532626B2 (da)
BE (1) BE881825A (da)
CA (1) CA1129794A (da)
CH (1) CH645890A5 (da)
DD (1) DD154494A5 (da)
DE (2) DE3051175C2 (da)
DK (2) DK149095C (da)
ES (1) ES8103171A1 (da)
FI (1) FI66427C (da)
FR (1) FR2449685B1 (da)
GB (1) GB2046737B (da)
HU (1) HU182069B (da)
IE (1) IE49743B1 (da)
IT (1) IT1175260B (da)
MX (1) MX6314E (da)
NL (1) NL191540C (da)
NO (1) NO153974C (da)
NZ (1) NZ192919A (da)
PH (1) PH15145A (da)
PL (1) PL124304B1 (da)
SE (1) SE453301B (da)
SG (1) SG6784G (da)
SU (2) SU1158048A3 (da)
ZA (1) ZA80962B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Mb−530a誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb−530b誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 HMG−CoAレダクターゼ阻害物質としてのテトラリン誘導体
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
NZ500870A (en) 1998-03-20 2002-03-01 Biogal Gyogyszergyar Metabolic controlled fermentation process for preparing mevinolin (lovastatin)
HUP0300073A3 (en) 2000-02-24 2004-10-28 Teva Gyogyszergyar Zartkoeruee Method of purifying a fermentation broth
EP1265884A4 (en) 2000-03-03 2003-05-21 Plus Chemical S A PROCESS FOR THE PURIFICATION OF LOVASTATIN AND SIMVASTATIN FOR REDUCING THE CONTENT OF DIMER IMPURITIES
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (da) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
WO2002063976A1 (en) * 2001-02-09 2002-08-22 Unilever N.V. Food product comprising soy protein and statins
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 k 생산방법
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (da) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ192919A (en) 1984-07-06
MX6314E (es) 1985-04-01
AU5567380A (en) 1980-08-28
NO153974C (no) 1986-06-25
PH15145A (en) 1982-08-24
SU969702A1 (ru) 1982-10-30
JPS55111790A (en) 1980-08-28
SE8001339L (sv) 1980-08-21
ZA80962B (en) 1981-03-25
ES488796A0 (es) 1981-02-16
DK21889D0 (da) 1989-01-18
NL191540C (nl) 1995-09-04
PL124304B1 (en) 1983-01-31
DK73080A (da) 1980-08-21
FI800506A (fi) 1980-08-21
JPS5925599B2 (ja) 1984-06-19
CA1129794A (en) 1982-08-17
GB2046737B (en) 1983-01-12
AU532626B2 (en) 1983-10-06
SE453301B (sv) 1988-01-25
FI66427B (fi) 1984-06-29
KR830002030A (ko) 1983-05-21
DE3006216A1 (de) 1980-09-04
BE881825A (fr) 1980-08-20
ATA92980A (de) 1983-07-15
DK149095B (da) 1986-01-20
IT8067262A0 (it) 1980-02-20
NL8001041A (nl) 1980-08-22
DD154494A5 (de) 1982-03-24
IT1175260B (it) 1987-07-01
CH645890A5 (de) 1984-10-31
NO800451L (no) 1980-08-21
NO153974B (no) 1986-03-17
DE3006216C2 (de) 1985-10-31
KR830002801B1 (ko) 1983-12-16
AT373915B (de) 1984-03-12
DE3051175C2 (da) 1989-12-21
FR2449685B1 (fr) 1985-06-28
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
ES8103171A1 (es) 1981-02-16
DK21889A (da) 1989-01-18
PL222120A1 (da) 1980-10-20
HU182069B (en) 1983-12-28
GB2046737A (en) 1980-11-19
SG6784G (en) 1985-02-08
IE49743B1 (en) 1985-12-11
IE800321L (en) 1980-08-20
DK149095C (da) 1986-06-16
NL191540B (nl) 1995-05-01

Similar Documents

Publication Publication Date Title
SU1158048A3 (ru) Способ получени монаколина @ ,обладающего антигиперхолестеримическим действием
CA1046439A (en) Physiologically active substances from penicillium citrinum
SE467975B (sv) Framstaellning av monakolin k
US3973608A (en) Microbial production of certain isoflavones
EP0335386B1 (en) Ks-506 compounds and process for the production thereof
US4358602A (en) Ebelactones and production thereof
US5079263A (en) Manumycin derivatives and the use thereof
EP0246975A1 (fr) Nouvelles substances immuno-suppressives, leur préparation par culture de streptomyces sp. (CBS 162.86) et les compositions pharmaceutiques qui les contiennent
HU189515B (en) Process for preparing new 20-dihydro-20,23-dideoxy-tylonolide /tylactone/ and esters thereof
SU980620A3 (ru) Способ получени сесквитерпенового производного
GB2111989A (en) New compounds having cholesterol-reducing activity
JP2873894B2 (ja) 環状デプシペプチドおよびその製造法
FR1465395A (fr) Composé nouveau, la décoyinine et son procédé de fabrication
US5306496A (en) Antibiotics NK374186A, NK374186B, NK374186B3 and NK374186C3, process for producing the same, and use of the same
EP0810198A1 (en) Sesquiterpene compounds
US4011140A (en) Process for producing antitumor compound
JPH06219989A (ja) 新規生理活性物質フルオスタチンaおよびb、その製造法およびその用途
JP2764759B2 (ja) 新規物質bt―38物質及びその製造法並びにそれを有効成分とする抗黴剤
US4992570A (en) UCN-1028A and UCN-1028C and process for the production thereof
JPS5840475B2 (ja) 新生理活性物質ml−236aおよびその製造法
JPH0532579A (ja) エストロゲン物質be−25327及びその製造法
JPS63239295A (ja) 新規物質ucy1003
JPS62132878A (ja) 新生理活性物質モナコリンm及びその製造法
JPH07278041A (ja) 抗腫瘍性物質be−24811及びその製造法
JPH05271267A (ja) Fr901459物質、その製法及び用途